home / stock / xlo / xlo message board
Subject | By | Source | When |
---|---|---|---|
Price target > 36.00 > HC Wainwright | crudeoil24 | investorshub | 02/10/2022 8:10:07 PM |
TODAY > Xilio Therapeutics, Inc. (Nasdaq: XLO), a | crudeoil24 | investorshub | 02/10/2022 6:56:10 PM |
Xilio Therapeutics, Inc. is a biotechnology company. The | crudeoil24 | investorshub | 02/10/2022 6:51:56 PM |
News, Short Squeeze, Breakout and More Instantly...
Xilio Therapeutics Inc. Company Name:
XLO Stock Symbol:
NASDAQ Market:
Xilio Therapeutics Inc. Website:
WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the appointment of Aoife Brennan, M.D., and James Sh...
Expect to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with microsatellite stable colorectal cancer (MSS CRC) in the third quarter of 2024 Plan to report clinical data for XTX101 and XTX301, a tumor-a...